Document:

Exhibit 10.18
​
Contract No. : 2022-106
Manufacture Site Leasing Agreement
​
Lessor (Party A):  Nanjing Biotech and Pharmaceutical Valley Construction and Development Co., LTD
​
Lessee (Party B):  Nanjing Dizhun Biotech Co., LTD
​
In accordance with the provisions of the Civil Code of the People's Republic of China and the relevant laws and regulations, and in combination with the arrangement of the application for renewal of the lease, the Life and Health Industry Development Management Office of Jiangbei New District, Nanjing, authorized Party A and Party B to enter into this agreement. Based on the principle of equality and mutual benefit, Party A and Party B, through friendly negotiation, have reached an agreement on the relevant matters of the house lease as follows:
​
Chapter I.  Condition and Purpose of Leasing
​
1.1 Party A agrees to lease to Party B the 7 and 8 floors of Block E, Phase II, Zhongtan Ecological Life Science Industrial Park, No. 3-1, Xinjinhu Road, Jiangbei New District, Nanjing, with a total construction area of 4,422.03 square meters. Party B has fully understood the current situation of the subject matter of the lease, and voluntarily leases according to the current situation.
​
1.2 The lease purpose is office, research and development. Party B warrants that during the lease term, Party B shall not change the use of the premises without obtaining the written consent of Party A. If Party B needs to increase, decrease or change the business type, it shall notify Party A in writing 30 days in advance.
​
Chapter II.  Term of leasing
​
2.1 Party B shall lease the property from July 1, 2022 to December 31, 2022. Among them, the rental period from July 1,2022 to December 31,2022 is the rental period.
​
2.2 Upon the expiration of the lease term, Party A shall have the right to take back the premises.
​
2.3 If Party B intends to continue to lease the premises before the expiration of this Contract, it shall submit a written application for renewal of the lease to Party A 30 days in advance. After obtaining Party A's consent, Party A and Party B shall sign a new lease contract. Otherwise, Party B shall be deemed to have voluntarily given up the priority right to rent the premises, and Party A shall have the right to rent the premises again after the lease term expires.
​

- 1 -

Chapter III. Rental fee standard and payment method
​
3.1 Rental unit Standard: Starting from January 1, 2020, the rent of the above real estate owned by Party A is RMB 45/square meter/month, and the rent will be adjusted according to the market conditions about every three years.
​
From July 1st, 2022 to December 31th, 2022, Party A shall collect the rent from Party B according to the rent standard of RMB 45/square meter/month; Party A shall issue a real estate lease invoice to Party B after receiving the real estate rent.
​
3.2 Property Management: Subject to the lease term of this Contract, Party B shall sign the Property Management Agreement with the property company before July 22, 2022, and the property management company shall issue the service fee invoice after collecting the property management fee.
​
3.3 Standard of equipment usage Fee: Party B shall pay the equipment usage fee to Party RMB    /    /square meter/month and Party A shall issue an invoice for the equipment usage fee to Party B.
​
3.4 Rent payment time: according to the principle of paying the rent first and then using it, it will be paid once every six months. The rental payment date of this contract is before July 22, 2022. If Party B fails to pay the rental beyond the agreed payment date, Party A has the right to unilaterally terminate this lease contract and re-lease the property leased by Party B, and Party B will unconditionally cooperate.
​
Payment method: Party B shall remit the rent to the account designated by Party A through the bank (Bank account number: 320006618018010016501, Account Name: Nanjing Biotech and Pharmaceutical Valley Construction and Development Co., LTD. Bank Info.: Bank of Communications Nanjing High-tech Development Zone Branch).
​
Chapter IV. Lease Deposit
​
4.1 Through friendly negotiation, Party A and Party B agree that the deposit for the lease of the house shall be RMB 480,000 (say total RMB four hundred and eighty thousand  yuan only). The last lease guarantee is extended to the current period, otherwise the property company entrusted by Party A has the right to refuse Party B's entry.
​
4.2 Party A and Party B agree that upon the expiration of the lease term or the early termination of this Contract for no reason attributable to Party B, Party A shall return the security deposit to Party B in full within 5 days after the completion of the lease (the security deposit shall be kept by Party A without interest during the lease term) when Party B does not default on the rent and other unpaid fees, and when the main structure of the house is not damaged and the ancillary equipment is in good condition at the time of the handover of the site.
​
​

- 2 -

Chapter V. Agreement on payment of water and electricity charges
​
5.1 Party B's water and electricity bills shall be calculated and paid according to the base of the number of water and electricity meters and the public part of water and electricity bills to be apportioned. The electricity of air conditioning system, ventilation system and other equipment shall be measured independently or apportioned at the same time.
​
5.2 Party B's water and electricity bills shall be collected monthly by the property company entrusted by Party A.
​
Chapter VI. Rights and Obligations of Party A
​
6.1 Party A shall have the right to collect equipment usage fee, rent, lease deposit, utilities and other related fees according to the contract. The utilities and electricity charges shall be collected by the property company entrusted by Party A in accordance with the contract.
​
6.2 Party A shall have the right to conduct proper inspection and supervision of the leased premises, but it shall not interfere with Party B's normal production, operation and office order.
​
6.3 During the validity of this Contract, Party A shall obtain Party B's consent in advance if it needs to make alterations to the property, which involve the use area (including ground, passageway, roof, etc.) of the leased property of Party B, and ensure that it will not affect Party B's normal work.
​
6.4 Party A guarantees that the leased premises of Party B have normal water and electricity. If Party B needs to increase the capacity of electricity, Party B shall submit a written application for increasing the capacity to Party A 10 days in advance. The application for capacity increase shall only be implemented with the consent of Party A, and the cost of capacity increase and transformation shall be borne by Party B.
​
6.5 Party A shall notify Party B 3 months in advance if it changes the property rights or has to terminate this Contract in advance due to special reasons. 6.6 Party A shall guarantee the safety of the office environment of Party B during the term of the lease, and entrust the property company to provide regular and fixed-point patrol service for the external environment of the leased premises.
​
Chapter VII. Rights and Obligations of Party B
​
7.1 Party B has the right to renovate, decorate or add new things to the leased premises and its affiliated facilities at its own expense.
​
7.2 Party B shall put forward reasonable written suggestions on the management of the property company and supervise the security, sanitation and service of the property
​
​

- 3 -

Company. If it is found that the property service is not implemented in accordance with the property agreement, it can report to Party A;
​
7.3 Party B shall have the right to renew the lease in writing to Party A 30 days before the expiration of the lease Contract. If Party B has complete fire protection, environmental protection and other safety-related procedures, has no record of payment arrears, and has not been punished by the environmental protection, fire control, safety supervision and other departments, the three conditions are met, Party A has the right not to renew the lease.
​
7.4 Party B shall abide by laws and regulations, go through procedures for safety, environmental protection, fire control, occupational health and other procedures and obtain the relevant record approval. All expenses shall be borne by Party B, and the non-household garbage shall also be treated in accordance with relevant regulations. The above expenses shall be borne by Party B.
​
7.5 Party B shall actively cooperate with the property company in fire inspection and have basic facilities for fire rescue.
​
7.6 Party B shall conscientiously abide by the relevant national policies and regulations, operate legally, and accept the supervision and inspection of relevant departments. At the same time, it is subject to the supervision and management of Nanjing Biomedical Valley.
​
 7.7 Party B shall timely pay the equipment usage fee, rent, house deposit, property management fee, water and electricity fee, etc. as agreed herein, as well as other fees payable to Party A according to the supplementary agreement hereof.
​
7.8 Without the consent of Party A, Party B shall not use the leased house for other purposes or sublease or lend it to other companies.
​
7.9 Party B shall normally use and take good care of the leased premises and all the facilities and equipment provided by Party A, and hand them over to Party A in good condition upon termination of the lease.
​
7.10 During the Lease Term, Party B shall be responsible for the safety of all activities of Party B's staff and other personnel related to Party B.
​
7.11 Within one month prior to the expiration of this Contract, if Party B clearly indicates that it does not renew the lease, if the address registered in the industrial and commercial, tax and other related certificates is in the leased premises hereunder, Party B shall go through the procedures for the change and transfer of the registered address of the certificate before the cancellation. If Party B applies for site GMP, GSP certification from health, drug administration and other industry authorities for the leased premises under this contract, Party B shall complete the cancellation registration formalities with 
​

- 4 -

relevant authorities before tendering the premises.
​
7.12 Party B has promised the development indicators in the investment agreement, supplementary agreement, co-construction agreement and other documents signed by Party B. If Party B fails to complete the indicators as agreed in the agreement, Party A shall have the right to take back the house in real time or not renew the house lease contract after the expiration, and Party B shall cooperate unconditionally.
​
7.13 If the whole building is leased, Party B shall be responsible for the repair, maintenance and annual inspection of all public facilities such as sewage station, fire control, power distribution room and elevator attached to the building. At the same time, Party B shall be responsible for the related expenses of maintenance in the leased building. If the maintenance is caused by Party B, Party B shall bear all the expenses; If it belongs to the maintenance of natural aging and non-human causes of damage, according to the following three conditions:
​
1 If Party B has not renovated or renovated the maintenance area city and damaged the external wall and the main structure of the building, Party B shall provide a professional identification conclusion, and Party A shall be responsible for the maintenance of the external wall leakage, roofing waterproof, glass curtain wall burst, wall settlement cracking and underground pipe network breakage caused by the main structure of the building;
​
(2) including but not limited to the sporadic maintenance works outside the above building structure, such as roof leakage repair, surface layer, roof ridge repair, internal and external wall plaiting, steel, wood doors and Windows renovation, doors and Windows glass, floor tiles and other vulnerable objects maintenance and replacement, shall be repaired by Party B;
​
3 Maintenance and maintenance of daily equipment, such as troubleshooting of water, electricity, heating, gas, steam and other equipment and maintenance of spare parts, shall be maintained by Party B.
​
Chapter VIII. Renovation and restoration of leased property
​
8.1 During the lease term, Party B shall renovate, decorate or add new things to the leased house and its affiliated facilities according to the laws and regulations, and keep it in the property company, and bear the expenses of renovation or transformation. If Party B is punished for failing to complete the relevant formalities, Party A has the right to terminate the lease contract.
​
8.2 Party B shall bear the corresponding losses and liabilities if it affects the normal work and research and development of other enterprises or causes damage to the public parts of the building during the decoration and operation period.
​
8.3 Upon termination of the lease, Party B shall restore the leased premises as they were when delivered by Party A, at the expense of Party B, or Party A shall be responsible for the restoration, but shall charge Party B the actual expenses incurred in the restoration
​

- 5 -

project. If Party B fails to take back the items left in the leased premises within 10 days after the termination, rescission and expiration of the Contract, Party B shall be deemed to give up the ownership of the property, and all the property shall be disposed of by Party A.
​
Chapter IX. Agreement on Safety and Environmental Protection
​
9.1 If the carrier sets up a sewage pretreatment station, Party A will only accept two conventional factors, COD and ammonia nitrogen, and other characteristic factors shall be treated by Party B. Waste water produced by the enterprise shall be discharged into the sewage pretreatment station to meet Party A's takeover standards. It is forbidden to discharge waste water such as fungicides and sterilization agents that have toxic effects on microorganisms into sewage treatment stations.
​
9.2 Responsibilities of Party A
​
A. The fire safety facilities provided by Party A shall be maintained and maintained by a third party maintenance unit and kept in effective condition;
​
B. Party A entrusts a third party property company to conduct regular safety inspections of the building;
​
C. As the lessor, Party A has the right to carry out safety and environmental protection inspection on Party B, and to report any illegal behaviors of Party B to the safety management department according to law.
​
9.3 Responsibilities of Party B
​
A. Party B is the subject of responsibility for production safety, and shall abide by laws, regulations and relevant documents on production safety, strengthen safety management, improve the responsibility system, strengthen security measures and improve safety conditions. Consciously accept the supervision, inspection and guidance of the departments responsible for the supervision and management of production safety, and implement the requirements for the management of production safety put forward by the supervision departments;
​
B. Implement the three simultaneous management of environmental protection facilities, safety facilities and occupational health prevention and control facilities, and carry out relevant work such as three-level safety education, training, emergency management, special equipment management, and occupational health management in accordance with the requirements of relevant laws and regulations;
​
C. Party B is equipped with safety and environmental protection facilities and systems suitable for its business activities and in effective operation to ensure compliance and effectiveness;
​
​

- 6 -

D. Party B shall be responsible for the operation and maintenance of safety facilities, environmental protection equipment and other safety related equipment in the leased area;
​
E. Party B shall, in accordance with relevant national laws and regulations, implement the investment in production safety and implement the special funds for exclusive use
​
F. Party A and Party B shall sign an agreement on production safety responsibility to clarify their respective responsibilities for production safety
​
G. Party A shall have the right to prevent and report to the production safety supervision and management department and other relevant departments if Party B has illegal production safety behaviors.
​
H. Party B shall be subject to Party A's unified coordination and management of its production safety work and shall be responsible for its production safety work according to law. In case of production safety accidents, Party B shall immediately report to the production safety supervision and management department of Jiangbei New District (emergency phone number: 025-58390119) and report to Party A's safety and environmental protection department (emergency phone number: 025-58640678)
​
I. Party B is obliged to actively cooperate with Party A and its entrusted property units to complete the inspection and supervision of production safety.
​
Chapter X.  Termination of the Contract
​
10.1 Party A and Party B may terminate this Contract upon amicable negotiation.
​
10.2 Party A has the right to terminate this Contract unilaterally under any of the following circumstances.
​
A. Party B fails to notify Party A in writing 30 days in advance of any increase, decrease or change of business type;
​
B. Party B fails to pay any of the initial rent, security deposit, subsequent rent, utilities and equipment usage fees after Party A collects them;
​
C. In the process of house improvement, Party B dismantleds and modifies the main structure and appearance of the house without authorization, and constructs other buildings within the scope of lease without authorization;
​
D. Party B uses the leased premises for other purposes other than those stipulated in this Contract or sublets or loans the leased premises to other companies;
​
E. Party B fails to go through the environmental assessment, safety assessment and fire control filing procedures in accordance with laws and regulations, and fails to conduct research and development activities in operation in accordance with laws and regulations;
​
F. Party B is unable to actively cooperate with the fire control inspection of the property
​

- 7 -

company and purchase basic facilities for fire control and first aid in accordance with laws and regulations;
​
G. Party B fails to enter or renovate the premises within one month from the effective date of the contract or the premises remain vacant for two months after the completion of the decoration;
​
H. Party B uses the property for illegal activities,
​
I. Party B's fire control and environmental protection assessment exceeds the acceptance period or fails to pass the acceptance;
​
J. If the fire control fails to be accepted or fails to pass the acceptance, Party B shall put it into use;
​
K. Party B shall put the environmental protection facilities into production or use if they are not completed, not accepted or not qualified;
​
L. During the lease term, Party B shall be subject to administrative penalties from environmental protection, fire control, safety supervision and other departments;
​
M. During the lease, Party B is found to have illegal or illegal behaviors;
​
N. During the lease term, Party B's business address or tax affairs shall be moved out of Party A's management scope.
​
10.3 If Party B cannot operate normally due to Party A's reasons and must terminate this contract in advance, Party B shall notify Party B 3 months in advance and Party B shall have the right to terminate this Contract unilaterally.
​
10.4 During the lease term, Party A has the right to unilaterally and unconditionally terminate this Contract if Party B has a safety incident or accident, and Party B shall restore the leased property to a blank state before leaving the premises. If any damage is caused to the property of other enterprises in the building, the public facilities of the building and other equipment, Party B shall bear the compensation, maintenance, engineering and other expenses.
​
10.5 Party A shall unilaterally terminate this Contract if Party B refuses to make rectification if Party B accepts the rectification and shall issue a rectification commitment letter to Party A. Party A shall supervise and check whether the rectification is in place. If the rectification is found to be inconsistent with the commitment letter or has not been rectified, Party A shall terminate this Contract unilaterally Unilaterally terminate this contract.
​
Chapter XI.  Responsibility for breach of Contract
​
11.1  In accordance with Paragraph 1.2 of this Contract, if Party B fails to notify Party A in writing 30 days in advance to increase, decrease or change the business type, Party B shall be deemed to have breached the contract and Party A shall have the right to unilaterally terminate the contract without returning the rent paid.
​
11.2  According to Clause 3.4 of this Contract, if Party B defaults on the equipment usage fee and rent for more than the agreed period, it shall be deemed to be in breach of
​

- 8 -

contract by Party B. In addition to timely repaying the equipment usage fee and rent, Party B shall also pay Party A a late fee starting from the date of breach. For each day of overdue, the late fee shall be levied at the rate of 5% of the overdue fee. If Party B does not pay any attention to Party A's written notice within one month, Party A has the right to terminate the Contract unilaterally.
​
11.3  In accordance with Clause 4.1 of this Contract, if Party B defaults on the equipment usage fee, rent, utilities, property management fee and other payments due, Party A shall have the right to detract from the deposit, and Party B shall make up the deposit deducted within 15 days after the deduction of the deposit, otherwise Party B shall be deemed to have breached the deposit, and Party A shall have the right not to refund the remaining deposit. If the deposit is still not enough to pay the arrearage fee after the deduction of all the deposit, Party B shall make up the remaining arrearage payment and pay the corresponding liquidated damages. If Party B still does not pay any attention to Party A's written notice within one month, Party A shall have the right to unilaterally terminate the Contract without any liability for compensation (or compensation).
​
11.4  According to Clause 5.2 of this Contract, if Party B fails to pay the utility bill within the time limit, it shall be deemed to be in breach of contract by Party B. In addition to timely repaying the utility bill, Party B shall also pay Party A a late fee starting from the date of breach. For each day of late payment, Party B shall be charged a corresponding late fee at the rate of 5% of the amount owed. If Party B fails to pay the water and electricity bills and overdue fees within one month after the written notice of the property company, Party A shall have the right to stop supplying the water and electricity to Party B, and Party B shall be responsible for the business losses arising therefrom. If Party B still does not pay any attention to Party A's written notice within one month, Party A has the right to unilaterally terminate the Contract without any liability for compensation (or compensation).
​
11.5  In accordance with Clause 6.4 of this Contract, if Party B arbitrarily increases the capacity and causes electrical equipment damage, the enterprises in the same building cannot operate normally and other consequences, Party B shall bear the economic losses resulting therefrom.
​
11.6  According to Clause 7.1 of this Contract, if Party B dismantates and modifies the main structure and appearance of the house without permission, or construct other buildings within the lease scope without permission during the process of house improvement, Party B shall be deemed to have breached the contract, Party A shall have the right to unilaterally terminate the Contract, refuse to refund the rent paid, require Party B to restore the original appearance of the house, and pay the corresponding liquidated damages.
​
11.7  If Party B fails to go through the formalities of environmental assessment, safety assessment, safety and fire control in accordance with laws and regulations and does not carry out research and development activities in operation in accordance with laws and
​

- 9 -

regulations, Party A has the right to unilaterally terminate the contract, refuse to refund the rent paid and require Party B to bear the corresponding liquidated damages.
​
11.8  In accordance with Clause 7.5 of this Contract, if Party B fails to actively cooperate with the property company in fire control inspection and purchase basic fire rescue facilities in accordance with laws and regulations, and the losses arising therefrom shall be borne by Party B, and Party A shall have the right to unilaterally terminate the Contract and not refund the rent paid if Party B still ignores the written notice of the property company for rectification within one month.
​
11.9  According to Clause 7.8 of this Contract, if Party B uses the leased premises for other purposes or subleases or loans the premises to other companies without Party A's consent, Party A shall notify Party B in writing to rectify the situation after finding it. If Party B still ignores the notice within one month from the date of receipt of the notice, Party A shall have the right to unilaterally terminate the contract and not refund the rent paid.
​
11.10  According to Clause 7.9 of this Contract, during the lease term or upon termination of the lease, Party B shall be responsible for the timely repair or compensation of the damage, malfunction or loss of the leased premises and its affiliated facilities caused by Party B's improper use, or Party A may repair the premises on behalf of Party A, and the maintenance expenses shall be borne by Party B. If Party B refuses to repair or compensate, Party B shall be deemed to have breached the contract and Party A shall have the right to deduct the maintenance fee from the deposit.
​
11.11  According to Clause 7.11 of this Contract, if Party B violates the terms of clause 7.11, Party A will not refund the lease deposit.
​
11.12  If Party B has the vacant house for 2 months (including all or part of the vacant house, and Party B has no water or electricity bill for 2 consecutive months, it is regarded as vacant), Party A has the right to unilaterally terminate this Contract and take back all or part of the vacant house without any liability for compensation (or compensation), and the rent paid will not be returned.
​
11.13  In case of breach of contract by Party A or Party B, the breaching party shall pay the non-breaching party three months 'rent of the current year as breach of contract penalty.
​
11.14  According to Clause 10.2N of this Contract, if Party B's business address or tax is moved out of the scope of Party A's management during the lease term, Party A has the right to unconditionally terminate the rent lease contract without any liability for compensation (or compensation) and to recover all the annual reduced rent from Party B.
​
11.15  According to Clause 10.2D of this Contract, if Party B uses the leased premises for other purposes or subleases or loans them to other companies during the lease term,
​

- 10 -

Party A shall have the right to terminate the lease contract without any liability for compensation (or compensation) and to recover all the annual reduced rent from Party B.
​
11.16  If Party B causes damage to the landscaping, fire control, electricity, gas, elevator, steam and other public facilities or building structures in the park during the renovation or operation, Party B shall restore the premises to the original condition within 10 days after receiving the written notice of the property and bear the relevant expenses. If Party B refuses to restore the premises, Party A shall have the right to unconditionally terminate the lease contract without any liability for compensation (or compensation).
​
11.17  If Party B fails to fulfill the relevant obligations and obligations in 9.3, Party A shall have the right to unconditionally terminate the rent contract without any liability for compensation (or compensation) and to recover all the annual reduced rent from Party B.
​
11.18  According to Clause 6.5 of this Contract, if the remaining lease term is more than 3 months, Party A shall refund the remaining rent and security deposit; If the remaining lease term is less than 3 months (including 3 months), Party A shall not only return the remaining rent and security deposit to Party B in time, but also pay liquidated damages equal to the rent of one month.
​
Chapter XII.  Responsibility for breach of Contract
​
12.1  In case of any dispute arising from the performance of this Contract, Party A and Party B shall settle the dispute through friendly negotiation. If no agreement can be reached through negotiation, the parties shall file a lawsuit with the people's court of the place where the lease is located.
​
Chapter XII.  Communication
​
Notices or other communications made by a Party pursuant to this Agreement shall be in writing and in the Chinese language, and may be sent by hand or registered post to the address of the other party hereinafter specified, or by fax to the fax number specified by the other Party, or by E-mail to the E-mail address specified by the other Party, and the date on which notices are deemed to have been effectively given shall be determined in accordance with the following provisions: by mail EMS or other express delivery shall be deemed to have been delivered three days after Posting; If it is a fax, it is the time when the fax has been sent successfully; In the case of an email, when the email has been successfully sent; If it is sent by special way, it is the date of the recipient's signature. Party A and Party B shall provide the following mailing address, recipient, E-mail and telephone number.
​
Party A:
Mailing address:
Contact:
Fax: 025-58641116
​

- 11 -

Email address:
Zip code: 210061
​
Party B:
Mailing address:
Contact: Fax:
Email address:
Zip code: 210061
​
If one party changes its mailing address or fax number, it shall notify the other party in writing as soon as possible in accordance with this article. If one party fails to notify the other party in time, the other party shall serve the documents, communications and notifications according to the contact method before the notification, and all consequences shall be borne by the non-notified party.
​
For the performance, modification, dissolution and dispute resolution of the contract, when the relevant documents are mailed and sent to the other party according to the above address, if the delivery fails (including but not limited to the unknown identity of the receiver, no sign for it, unknown address, address relocation, long-term non-acquisition, electronic data being returned or rejected, etc.), the date of return of the documents shall be regarded as the date of delivery; When the documents are delivered directly at the above mailing address, if the delivery fails (including but not limited to no sign, unknown address, address relocation, rejection, etc.), they can be delivered by detaining or posting documents, and the date of detaining or posting documents shall be regarded as the date of delivery.
​
Chapter XIV. Effective Agreement and Others
​
14.1 Party A or Party B shall not disclose any contents of this contract (especially rent, security deposit, etc.) and the other party's business information to any third party without the consent of the other party.
​
14.2 For matters not covered in this contract, Party A and Party B can negotiate and sign a supplementary agreement.
​
14.3 This contract comes into force after being sealed (signed) by both parties.
​
14.4 The original of this contract is in octuplicate, with Party A holding five copies and Party B holding three copies.
​
​
​
​
​
[No text, the signed page]
​
Nanjing Biotech and Pharmaceutical Valley Construction and Development Co., LTD
​
​

- 12 -

	​

	​

	​

	Signed:
	/s/ LIU Di
	   
	​

	​
	​
	​

	​
	​
	​

	​
	​
	​

	​
	​
	​

	Nanjing Dizhun Biotech Co., LTD
	​
	​

	​
	​
	​

	​
	​
	​

	​
	​
	​

	Signed:
	/s/ Zhang Heping
	​
	​

​

- 13 -Exhibit 10.19
	
	

2019	Di)a)C)ar
t)a,	I
nc.	All

rights	reserved.

e

DIACARTA

CLINICAL

TESTING

&

DISTRIBUTION

AGREEMENT

Nonagen Bioscience Corporation

Date	Prepared

DiaCarta,	Inc.

Nonagen	Bioscience	Corporation

A
pril	26
,	202
2

4385	Hopy)ard	Rd,	Ste	100

Ple)as)a
nto
n,	)CA	94588

United	St)ates

P:	+1	510
-
878
-
6662

F:	+	1	510
-
735
-
8636

E:	inform)ation@di)ac)art)a.com

3680	Wilshire	Blvd

Ste	P04
-
1399

Los	Angeles,	)CA	90010

United	St)ates

P:

E:
info@non)agen.com

	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen

P
)age
2

of	11

THIS	AGREEMENT	IS	MA
DE	THIS
DAY

A
PRIL

27,
202
2

BY	AND	BETWEEN
NONAGEN	BIOSCIENCE	C
ORPORATION

WITH	ITS	PRIN)CIPAL	P
LA)CE	OF	BUSINESS
LO)CATED	AT
3680	WILSHIRE	BLVD	S
TE	P04
-
1399,	LOS	ANGELES,	)C
A
9001
0
,	USA	(THE	")COMPANY"
))	AND
DIACARTA,	INC.
WITH	ITS	PRIN)CIPAL	P
LA)C
E	OF	BUSINESS	LO)CATE
D

4385
H
OPYAR
D	RD,	STE	100,	PLEAS
ANTON,	)CA	94588,	USA

(THE	"
)CLINI)CAL	LABORATORY
"))Cla.

Definitions
..		For	purposes	of	this	Agreement,	the	terms	below	sh)al
l	h)ave	the	me)anings	set	forth	below.

Services
:

me)ans	)any	l)abor)atory	testing	services

or	p)art	thereof	sol
d

or	per
forme
d	by
)Clinic)al	L)abor)atory	using	)a

Product
Kit

for	one	of	the	3	indic)ations:	bl)adder	c)ancer	surveill)ance,	ev)alu)ating	hem)aturi)a	)and	predicting
response	to	B)CG
..

Product	Kit
:
me)ans	the

)Comp)any
’
s

b
l)adder	c)ancer	di)agnostic
k
it,
Oncuri)a
®
..

E
xclusi
ve	Per
iod
:	me)ans	the	period	beginning	on	the	Effe
ctive	D)ate	)and	ending	upon	FDA	)approv)al	or	cle)ar)ance
for	one	of	the	3	indic)ations	noted	)above	unless	termin)ated	sooner	pursu)ant	to
P)art
9

(
B))
..

Field
:

me)ans	the	field	of	bl)adder	c
)a
ncer	identific)ation,

screen
ing,	s
t)aging,	predisposition,	di)agnosis,	prognosis,
monitoring,
prevention,

or	tre)atment	selection	thereof	in	hum)ans

for	clinic)al	decision	m)aking.

Prim)ary

Territory
:
In	North	Americ
)a,	including	United	St)ates	)and	)C)an)a
d
)a.

Supplier
:	me
)ans	the	)Co
m
p)any
’
s	desig
n)ated	supplier	of	the	Product	Kit.

NOW,	THEREFORE,	IN	)C
ONSIDERATION	OF	THE
PROMISES	HEREINAFTER

MADE	BY	THE	PARTIES
HERETO,	IT	IS
AGREED	AS	FOLLOWS:

PART	1.	APPOINTMENT
OF
CLINICAL
TESTING	RIGHTS

a.

Te
s
ting

Right
s
..

)Comp)any	hereby	gr)a
n
ts	to

)Clinic
)al	L)abor)atory
the	)ability	to
use	the
product	kit
to	test,
perform,	m)arket,	offer	for	s)ale,	sell	)and	otherwise	commerci)alize	Services	solely	within	the	Field	during	the
Term	)as	)a	l)abor)atory	developed	test	(LDT))Cha.

T
he
services
gr)anted	under

this
s
ectio
n

sh)all

be	exclusive

)and
non
-
tr)ansfer)able

t
o	)C
linic)al	L)abor)atory

in	the	Field	in	the	Prim)ary	Territory	during	the	Exclusive	Period,	)and
)autom)atic)ally	becomes	non
-
exclusive	there)after.	Non)agen	reserves	the	right	to	gr)an
t

Dr.	)Ch)arles	Rosser	the
right	t
o

use
the
P
ro
duct
K
it
f
or	the	purposes	of	c
onducting
c
linic)al
t
ri)als.	Furthermore,	Non)agen	reserves	the
right	to	gr)ant
other
rese)archers,	)at	its	sole	discretion,	the	right	to	use	the
P
roduct
K
it

solely	for	the	purposes
of	)ac
)a
demic	rese)arch.

b.

Obligation.

T
h
e
)Cli
nic)al	L
)abor)atory

will	t)arget
customers	who	)are	clinici)ans	or	clinici)an	groups	who	ev)alu)ate
)and/or	m)an)age	bl)adder	c)ancer	p)atients
)and	di)agnostics	l)abor)atories
..
Licensed
S
ervices

will	be	uplo)aded	in
the

)Clinic)al	L)abor)ato
r
y	di)agnostic	test	menu

for	thei
r

cust
o
mers	t
o	e
nsure	)accessibility	for

the
p)atients,
tre)ating	physici)an
s

)and	di)agnostics	l)abor)ator
ies
..	The
)Clinic)al	L)abor)atory

will	)also	t)arget	clinici)ans	working	on
Person)alized	Medicine	)and	other	st)akeholders	such	)as	poli
c
y	m)akers.

)Clinic)al	L
)a
bor)at
ory

)a
gr
ees	to	use	commerci)ally	re)ason)able	efforts	to	commerci)alize	Services.

c.

Pr
oduct
..

)Comp)any	h)as	)adopted	)a	sep)ar)ate	onbo)arding	process	to	)authorize	)Clinic)al	L)abor)atory	to	pl)ace
Purch)ase	Orders	with	the	)Comp)any’s	Supp
l
ier	for	the	product.	Supplier	i
s

then

)auth
or
ized	to	sell	Product	to
)Clinic)al	L)abor)atory	under	Supplier’s	sep)ar)ate	purch)ase	)a
greement	with	)Clinic)al	L)abor)atory.

	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen

P
)age
3

of	11

d.

Competitive	Products.

)Clinic)al	l)abor)atory
m)ay
not	offer	other
hum)an	bl)adder	c)ancer	di)agno
s
tics

tests	)as
l)abor)atory	developed	te
sts
(
LDTs
))

or
in	vitro	di)agnost
ics	(
IVDs
))
..

P
A
RT	2.	PRIC
IN
G	AND	PURCHASING

For	purposes	of	this	Agreement,	“Net	S)ales”	me)ans	the	revenue	gener)ated	by	)Clinic)al	L)abor)atory	from	the	s)ale
of	the	Product	Kits	but	excludes

)any:	(i))

discounts	)allowed	in	)amounts

custom)ary	in
t
he	tr)ade;	(ii))

s)ales	t)ariffs,
d
u
ties	)and/o
r
t)axes	imposed	on	s
uch	Product;	(iii))

outbound	tr)ansport)ation	prep)aid	or	)allowed;	)and	(iv))

)amounts
)allowed	or	credited	on	returns.		For	the	)avoid)ance	of	doubt,
no	deduction	from	Net	S)ales	sh)all	be	m
)ade	for
commis
s
ions	p)aid	to	individu)als	(wheth
e
r	independ
en
t	s)ales	)agents	or
persons	regul)arly	employed	by	)Comp)any
or	)Clinic)al	L)abor)atory))Cha.

The	pricing	)and	purch)asing	of	the
P
roduct
K
its	to	the	)Clinic)al	L)abor)ator
y	will	be	set	forth	in	the	)Clinic)al
L)a
bor)atory’s	sup
p
ly	)agreement	with	the	)Comp)any’s

S
upplier.

)Clinic)al	L)abor)atory
will	ret)ain
sixty

six

percent	(
6
6
%))Cva	of	the
net	s)ales,	while	)Comp)any	will	be	p)aid
thirty	three

percent	(
33
%))Cva	of	the	net	s)ales.	)Clinic)al

L)abor)atory

will	remit	to
)Comp)any

th
is

rem)aining	per
c
ent)age	within	thirty
(30))	d)ays
o
f	its	rece
ip
t	of	the	rel)ated	p)ayments	from	the	third	p)arty.

)Comp)any	sh)all	h)ave	the	right,	upon	re)ason)able	notice	to	)Clinic)al	L)abor)atory,	to	)audit	the	books	)and	recor
ds	of
)Clinic)al	L)abor)atory

in	order	to
determine	the
)a
ccur)acy	of	the	Product	Percent)a
g
e	P)ayments

m
)ade	pursu)ant	to
this	Secti
on.

The	costs	of	such	)audit	sh)all	be	p)aid	by	)Comp)any	unless	the	)audit	discovers	)an	underp)ayment	of
five	percent	(5%))	or	more,	in	whic
h	event	the	costs	of	s
uch	)audit	sh)all
be	p)aid	by	)Cli
n
ic)al	L)abor)atory.		)Comp)any
m)ay	e
x
ercise	suc
h
)audit	right	no	more	th)an	once	per	ye)ar.

Late	Payment
..

Any	sum	of	money	due	to	)Comp)any	under	this	Agreement	which	is	not	duly	p)aid	on	time	sh)all
be)ar	interest
from	t
he	due	d)ate	of	p)ayment	until	the

)actu)al	d)ate	o
f

p)ayment	)at	the	r)ate	of	one	)and

)a	h)alf
per
ce
nt	(1.5%))Cha	per	month	)accumul)ated	on	)an	)annu)al	b)asis.

PART	3.
DILIGENCE

Specific	Diligence	Milestones
..
)Clinic)al	L)abor)atory
)agrees	to	use	commerci)ally	re)ason)ab
le	efforts	to	meet	)all	of
the	followin
g	due	diligenc
e

requirements
:

•

A
chieve	the	)Com
m
erci)al	L)au
nc
h	D
)ate
within
t
wo	months
(2))
following

the	su
ccessful	v)alid)ation	of	the
product	in	the	)Clinic)al
L)ab
or)atory
:

•

P
erform	)and	sell	)at	le)ast
Two
Thous)and

F
iv
e
H
un
dred

(2,
5
0
0
))
tests

th)at	)are	Serv
ices	wit
hin	the	first	ye)ar
of	the	)Commerci)al	L)aunch
D
)ate
(cumul)ative
,	o
ver	such
o
ne
(
1
))	ye)ar	period))
;

•

P
erform	)and

s
ell	)at
le)ast

S
even

Thous)and

Five
Hundred

(
7
,
5
00))Cga
tests	th)at	)are	Services	within	two	(2))
ye)ars	of	the	)Co
mmerci)al	L)aunch	D)ate

(cumul)ative,	over	such	t
wo	(2))Cva	ye)ar	period))Cva;

•

P
erfo
r
m	)and	sell	)at	le)ast
F
ifteen
Thous)and
(1
5
,
000))Cga
tests	th)at	)are	Services	within	three	(3))

ye
)a
rs	of	the
)Co
m
merci)al	L)aunch	D)ate	(cumul)ative,
o
v
e
r

s
uch	three	(3))Cha	ye)ar	period))Cha	)and

•

M
)a
int)ain

Twenty

Thous)and	(
20
,00
0
))

tes
t
s
s)ales
)annu)ally

going	forw)ard
..

In	the	event	)C
linic)al	L)a
bor)ator
y	f)ails	to	meet	its	oblig)ations	described	)above	)an
d	if	ope
n	rece
i
pt	of	writte
n	not
ice
of	such	f)ailure

is	not	cured	by	)Clinic)al	L)abor)atory	w
ithin	one	hundred	)and	tw
enty	d)ays	(120))Cga	d)ays,	then	)a
s

)Comp)any’s	sole
)and	exclusive	remedy,	)Comp)any	s
h)all	h)ave
the	rig
ht	to	termin)ate	the	Agreement	upon	written
notice

to	)Clin
ic)al	L)a
b
or)atory.

	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen

P
)age
4

of	11

PART
4
..	MARKETING	AND
SALES
SUPPORT

A.

Sales.

)Clinic)al	L)abor
)atory
sh)all	use	its	best

efforts	to	promote	the	s)ale

)and	distribution

of	the	Product

Kit

)and
to	prov
ide	)adequ)a
te	supp
ort,	which	efforts	sh)all	include	the	following:

i.

Provide
)an	)adeq
u
)ate,	tr)ained

s)al
es	)and	technic)al	st)aff	to	promote	the	s)a
le	)and	support	of
the
Product

Kit
;

ii.

Undert
)ake	promotion)al	c)amp)aigns	)an
d

c)anv)as	prospect
ive	users	to	stimul)ate	the	s)ale
s	of	Produ
ct

Kit
;

iii.

Provide	)Comp)any	with	forec)asts	every	qu)arter	of	its	pro
b)abilit
y

requirement
s	fo
r	the	next	six
months	for	Product,	such	fore
c)asts	to	be	in

such	m)anner	)and	on	form
s	to	be	specified	by	)Comp)any

)and	)agreed	to	by

)Clinic)al	L)abor)atory
;

iv.

Furtherm
ore,	)all
)C
linic)al

L)abor)atory

employees	in	direct	cont)act	with	custome
rs	must	h)ave

)a
biomedic)a
l

b)ackground	)and	experience.

B.

Advertising.

)Comp)any
)and	its	)af
fili)ates
sh)all

)assist	the

)Clinic)al	L)abor)atory

on	)all

)a
dvertising,	s)ale
s	promotion,
)and	publi
c	rel)atio
ns	c)amp)aig
ns	to	b
e	conducted	)and	sh)all	provide	necess)ary	technic)al	in
form)ation	)an
d

)assist)ance
..

C.

Training.
)Comp)any
)and	its	)affili)ates
sh)all	furnish	tr)ainin
g	of
)Clinic)al	L)abor)atory'
s
s)ales	)and	technic)al
repre
se
nt)atives	)at	v)ari
ous	times	mutu)ally	)agreed	to	by

the	P)arti
es	)and
)Comp)any	sh)all	design)ate	loc)ations	)as
for	this	purpos
e.	Enrollmen
t

in	tr)ainin
g

courses	sh)all	be	limited	to	)a	re)ason)able	number	of	persons	w
ho	sh)all
be	sufficiently
qu
)alified	to	t)ake	the	cours
es
..	Tr)aining
m)ay
b
e	provided	using	on
-
line	tools
,

w
ebin)ars

or	in
-
p
erson	modules
..

D.

Regional	Technical	Support.

Th
e
)Clinic)al	L
)a
bor)atory
wi
l
l	)assign	one	design)ated	employee	to	)act	)as	technic)al
support
for	the	)Comp)any
’
s

P
roduct

Kit
..	The	)Comp)any	will	prov
id
e	regul)ar	worksh
ops	)and	)adv)anced	tr)aining
on	)al
l	Product

Kits
..

PART
5
..	DELIVERY

A.

Product.

)Comp)any	h)as	)ado
pted	)a	sep)ar
)a
te	onbo)ardi
n
g	process	to	)authorize
)Clinic)al	L)abor)atory

to	pl)ace
Purch)ase
Orders	with	the	)Comp)any’s

Supplier	for	the	product.
Su
pplier	is	then	)a
uthorized	to	sell	Product	to
)Cl
inic)al	L)ab
or)atory

under	Supplier’s	sep)ar)ate	purch)ase	)agreement	with
)C
linic)al	L)abo
r
)atory
..

B.

Pu
r
chase	Orders.

)Clinic)al	L)abor)atory
sh)all	order	Product
Kits
by

written	notice	to	)C
omp)an
y’s	Supplier
..	E)ach
order	sh
)al
l	specify	the	nu
mber	of	units	to	be	shipped,	th
e	type	of
units	t
o	be	shipped	()as	identified	by

Supplier’s
c)at)al
ogue	number
d
esign
)ations

indic)ated	in	the	Price	List))CIAa	including	)all	option)al	fe)atures,

)and	the
desired	method	o
f	shipment.

C.

Shipment
..

All	shipments	of

Product	Kits
sh)all	be	m)ade	by
Supplier
d
esign)at
ed	by	)Comp)any	to	ship	product
..

)Comp)any	sh)all	no
t	be	in	def)a
u
lt	by	re)aso
n

of	)any	f)ailure
of	Supplier	to	provide	the	Product	Kits
,	n
or
sh)all	the
)Comp)any	)at	)any
time	be	li)able	for

)any	inci
de
nt)al,	speci)al	or

consequenti)al	d)am)ages.

PART
6
..	PROPRIE
TARY	RI
GHTS

	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen

P
)age
5

of	11

A.

Use	of	Company	Name.

)Comp)any	expressly	proh
ibits	)any	direc
t

or	indirec
t

use,	reference	to,	or	other
employment	of	its	n)ame,	tr)adem)ar
ks,	or	tr)ade	n)ame	exclusi
vely	licensed	to	)Comp)any,	e
xc
ept	)as	specified

in
this	Agreement	or	)as	expres
sly	)author
ized	by

)Comp)any	in	writing.	All	)a
dvertising	)and	other	pr
omotion)al
m)ater
i
)al	will	be
s
ubmitted	to	)Comp)any	)at	le)ast
14

working	d)ays	in	)adv)ance	)and	w
ill	only	be	used	if	)Comp)a
ny
consents	thereto,	which
co
nsent	sh)all	not
be	unre)ason)ably	withheld.	Furth
ermore,	Th
e	)Comp)a
ny	will	use
best	comm
erci)al	efforts	to	respond	wi
thin	3	working
d
)ays	from	th
e

initi)al	d)ate	of	submission.	)Comp)any
hereby	)authorizes	)and	re
quires
)Clinic)al	L)abor)ator
y's
use	of	the	)Comp)any's	in
si
gni)a	or	letterin
g	which	will	be
on	the	products

)at	the	ti
me	of	t
he
delivery.	)Comp)any	hereby	)authorizes	the
)Clinic
)al	L)abor)atory's

use	of	the
l
ogo	set	forth	below.	The
)Clinic)al	L)abor)atory
sh)all	submit	to
the

)Comp)any
in	writing	fu
ll	p)articul)ars	prior	to
)any

u
se	of	the

)Comp)an
y’s
logo,	on	st)ationery,	invoic
es,	promot
ion	m)at
eri)al	or	otherwise,	)and	sh)all	not
proceed	with	su
ch	use	unless	)a
n
d	until	the

)Comp)any's	written	)approv)al	sh)all	h)ave	been	received.

i.

)Co
mp)any’s
logo	sh)all	be	the

following:

ii.

If	the	)autho
ri
zed	logo	is	used

on	)any	st)ationery,	invoices,	p
romotion	m
)ateri)al

or	otherwise	by

)Clinic)al	L)abor)atory
,
)Clinic
)al	L)abor)atory
w
i
ll,	on	term
i
n)ation	of	this	Agreement,	or	upon	request	of
)Comp)any,	discont
inue	the	use	of	such	logo

on	)any	st)ationery,	invoice
s,

promotion	m)ater
i)al	or
otherwise	)and	there)after

will	not
use,	ei
ther	directly	or	indirectly	in	connection	with	it
s	business,
su
c
h

logo	or	)an
y

other	n)ames,	titles	of	expressions	so	ne)arly	resembling	the
s)ame	)as	would	likely
le)ad

to	confusion	or	uncert)aint
y,

or	to	deceive	t
he	public.

B.

Patent	Indemnity.

)C
omp)any	)agr
ees,	)at

its	own	expense,	to	indemnify,	defend	)and	hold	h
)armless

)Clinic)a
l

L)abor)atory

)and	its	customers	from	)and	)ag)ainst	every	expense,	d)am)age,	cos
t	)and	loss	(including	)att
orneys'
fees	incurred))	)and
to

s)atisfy	)all	jud
gments	)and	decrees	resulting	fr
om	)a	cl)aim
,	suit
or	proceeding	insof)ar	)as	it
is	b)ased	upon	)a
n	)alle
g)ation	th)at	the

Product
Kit

or	)any	p)art	thereof	furnished	by	)Comp)any	or	)any	process
which

is	pr)acticed	in	the	cust
om)ary	use	of	the	Product
Ki
t
is	or	h)as	been	i
nfringing	upon	)any	p)atent,
copy
right	or	p
ropriet
)ary	right,	if	)Comp)any	is	notified	promp
tly	of	suc
h	cl)aim	in	writ
i
ng	)and	give
n

)authority,
)and	full	)and	proper	inform)ation	)and	)assist)ance	()a
t	)Comp)any's	expense))	for
the	defense	of	s)ame.	In	c)as
e
the
Product

Kit
,

or	)any	p)art	thereof,	in	such	s
uit	is	hel
d	to	co
nstitute	)an	infringement	)and	the	use
of	s)aid	Prod
uct
Kit
or	p)art

is	enjoined
,

)Comp)any	sh)all,	in	its	sole	discretion	)and	)at	its	own	expense
,	either	procure	for	the
indemnitee	the	right	to	con
ti
nue	using	s)aid	P
roduct
Kit
or	p)art	or	repl)ace	o
r	modify	t
he	s)ame

with
nonperform)ance	or	c)ap)acity
or	)affect	its	co
mp)atibility	wit
h

the	h)ardw)a
r
e	or	firmw)are	comprising	the
Product
Kit
or	the	softw)are	util
ized	thereon.

C.

Drawings
and	Data.

The	)Comp)any	suppl
ie
s	)all	necess)ary
d)at)a	for	the	proper
test,	oper)a
tion,	use

)and
rep
orting
of	its

Product	Kit
..
Portions	of	this	d)at)a
)are	propriet)ary

in	n)ature	)a
n
d	will	be	so	m)arked.	The

)Clinic)al	L)abor)atory
)agrees	to	)a
bide	by	the	terms	of	such

m)arkings	)and	to	be	li)ab
le
fo
r	)all	loss	or	d)a
m)age
incurred	by	the	)Comp)any	)as

)a	result
of	the
improper	or	un)authorized	use	of	such	d)at)a.	The	)Co
mp)any	ret)ains
f
o
r	itself	)al
l

propriet)ary	rights	in	)and	to	)all	designs,	clinic)al	d)at)a,	eng
ineering	det)ails,	)and	oth
er	d)at)a
pert)aining	to	)an
y

P
ro
duct	Kit
specifi
ed	in	the	contr)act	)and	to	)all	d
iscoveries

invent
ions,	p)atent	rights,	etc.,

	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen

P
)age
6

of	11

)arising	out	of	w
ork	done	in	connectio
n

with
the	co
ntr)act	)and	to	)any	)and	)all
Product	Kits
developed	)as	)a
result
thereof,	including	th
e	so
le	right	to	m)anuf)acture	)any

)a
nd	)all	such	prod
ucts.

P
ART
7
..	CONFIDENTIALIT
Y

A.

During	the	Ter
m	of	this

Agreement

)and	for	)a	period	of	two

(2))	ye)ar

the
re)after,	e)ach	P)arty	(“Receiving
P)arty”))Cga	sh)all	tre)at	)all	d)at)a,	inform)ation	)and

m)ate
ri)als

disclosed	or	provid
ed	by	the	other	P)arty	(“Disclosing
P)arty”))Cga	in

perform)ance	of	the

Services	)and	the	M)ateri)als

(
“)Confidenti)al	Inform)ation”))Cla	)as	confidenti)al	)and
propriet
)ary	of	the	Disclosing	P)arty	)and	sh)all	not	permit	such	)Confidenti)al	Inform)ation	to
be	disclosed	to	or
used	b
y	)any	third

p)arty

)and	sh)all	not	use	)Confident
i)al	Inform)ation	for	)any	purposes	other	th)an	for
the
perform)ance	of	the	Services	or	other	)activities	cons
istent	with	this

Agreement.

Both
)Cl
inic)al	L)abor)atory

)and	)C
omp)any

m)ay	receive	)and
sh)al
l	keep	confidenti)al	)a
n
y	info
rm)atio
n	tr)ansmitted
in	confidence	from

one	P)arty	(the	“Disclosing	P)arty”))Cha	to	the	other

P)arty	(the	“Receiving	P)arty”))Cga.	T
he

oblig)ations	of	the	Receiving	P)arty	reg)arding	c
onfidenti)a
lity	for	)any	info
rm)ation	disclosed	hereunder	s
h)all

not
include:

i.

Infor
m
)ation
which
is	or	becomes	publicly	known	thr
ough	no	wrongful	)act	of	the	Receiving	P)arty;

ii.

In
form)ation	which	w)as	known	to	the
Re
ceiving	P)arty	prior	to	signing	this	document	)as

evidenced

by
its	written	records;	)and

iii.

Inform)ation	which

is
received	by	the	Recei
v
ing	P)a
rty	fr
om	)a	third	p)arty	without	restric
tion	of
confidenti)ality;	)and

iv.

Inform)ation	th)at
is

independently	developed	by	or	on

b
eh)alf	of	the	Receiving	P)arty	without	reli)ance
o
n	the	)Conf
identi)al	Inform)ation	received	hereunder,	)as	re
)ason
)ably	evidenced	by	its

writte
n	reco
rds.

B.

A	Receiving	P)arty	sh)all	d
isclose	the	)Confidenti)al	Inform)ation	only
to	its

employees	who	must	h)ave	)access	t
o
the	)Confidenti)al	Inform)ation	in	order	to	perfor
m	services

under	this	Agreement.

C.

A	Receiving	P)arty	sh)a
ll	n
ot	use	)any	)Confidenti
)a
l	Info
rm)atio
n	except	for	the	perform)ance	of
the
Services
..

D.

If	disclosures	of	)Confidenti)al	In
form)ation	)are	requested	by

)any	gover
nment)al	)agency,	the	Receiving	P)arty
sh)all	promp
tly	notify

the	Disclosing	P)arty	of	such	request.

E.

If	)Comp)an
y	instructs
)Clinic)al

L
)abor)atory

no
t
to	comply	with	such	request	f
or	disclosure	)and	i
ndemnifies
)Clinic)al	L)abor)ator
y

)ag)ainst	loss,	cost,	or	e
xpense	)ari
sing	from	deni)al	of	the	request,
)Clinic)al	L)abor
)atory

sh)al
l
not	rele)ase	)any

such	)Confidenti)al	In
form)ation	except	where	such	disc
l
o
sure	is	comp
elled	by	court	ord
er	or
)applic)a
ble	l)aw.	In	the	event	such	disclosu
re	is	require
d	by	)a	v)alid	order	of	)a	co
urt	or	oth
er	government)al
body	h)aving	jurisdiction	or	by
)applic)able

l)aw,
)Clinic)al	L)a
bor)atory

m)ay	disclose

)Confidenti)al	Inform)ation,
witho
u
t

viol)ating	i
ts	oblig)ations	under	this
Agree
ment,	provided	th)at
)Clinic)al	L)abor)atory

gives	re
)aso
n)able
prior	written	not
ice	to	)Com
p)any	of	such	required	disclosure.

PART
8
..	WAR
RANTY

A.

Kit

Warranty.

)Comp)any	w)arr)ants	th)at	the
P
roduct
K
its	)are	free	from	defect

)a
nd	)are	fit	f
or
its	specific
purpose	unless
the	shipping	con
t)ainer	h)as	been	d)am)aged	in	tr)ans
it.	D)am)age	constitutes	the

shipping
cont)ainer	h)as

been	opened	()and	therefore	possibly	t)ampered	w
ith))CIAa
or	h)a
s	the	p)ack)aging	)and	insul
)ating
m)ateri)al	been
compromised
such	th)at	the
P
roduct

K
it	m
)ay	h)ave	subjected
to	un)accept)ably
high

	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen

P
)age
7

of	11

temper)atures.	)Comp)any	does
not	w)arr)ant	the	perform)anc
e	of	the

P
roduct

K
it	pe
rformed	by	1))	untr)ained	or
unqu)alified	personne
l	2))CIAa
when
used	with	equipment	o
r	re
)agents	not	specified	by
the
)Comp
)any.	THIS
)CONS
T
ITUTES	THE	S
OLE	WARRANTY	WITH
REGARDS	TO
PRODU
)CT
KITS	MADE	BY	)COMPANY	EITHER
E
XPRESSED	OR	IMPLIED.	THERE

ARE	NO	OTHER	WARRANTIE
S	EXPRESSED	OR	IMPLIED	WHI)CH	EXTEND
BEYOND	THE
FA)CE
HEREO
F
,	HEREIN,	IN)CLUDING	THE
IMPLIED	WARRANTIES	OF	MER)CHANTAB
ILITY	AND
FITN
E
SS	FOR	A	PAR
TI)CULAR	PURPOSE.	I
N	NO	EVENT	SHALL

)COMPANY	BE	LIABLE	FOR	ANY	IN)CID
ENTAL	OR
)CONSEQUENTIAL	DAM
AGES	AND	)COMPANY’S	REME
DIES	SHALL	BE	LIMITED	TO	REPAIR	OR	REPLA)CEMENT
OF	NO
N)CONF
O
RMING
KITS
..

B.

Misus
e	of	Product.

Any	t)ampering,	misuse	o
r	negligence
i
n	h)andling	o
r	use	of	Product
Ki
ts
renders	the
w)arr)anty	void.	Further,	the	w)arr)a
nty	is	void	if,	)at	)an
y	time,

)Clinic)al	L)abor)atory

)attempts	to	m)ake	)any	intern)al
ch)anges	to	)any	o
f	the

comp
onents	of	the	Product

Kit
;	if	)at	)any	time	the	power	suppli
ed	to	)any	p)ar
t

of	the
Prod
uct
Kit
exceeds	the

r)ated	toler)anc
e;	if	)any	extern)al	device	)att)ache
d	by
)Clinic)al	L)abor)at
ory

cre)at
es
conditions	exce
eding	the	toler)ance	of	the	Product

Kit
;	or	if	)a
ny	ti
me	th
e	seri)al	number	pl)ate

is	removed	or
def)aced.	USE	OF	PRODU)C
T
KIT
THAT	RE
N
DERS	THIS	WA
RRANTY	VOID	WILL	BE

DEFINED	TO	IN)C
LUDE	ALL	OF
THE	POSSIBILITIES	DES
)CRIBED	IN	THIS	PARAGR
APH,
TOGETHER	WITH	ANY	PRA)C
TI)CE	WHI)CH	RESULTS	IN
)CONDITIONS	EX)CEEDING	THE
DESIG
N	TOL
ERAN)CE	OF	THE	PRODU)CT
..

PART
9
..
TERM	AND	TERMINATION

A.

Ter
m.

The	term	o
f

this	Agreem
ent	sh)all	commence
on	the	Effectiv
e	D)ate	)and	continue	for	)a	period
of	three
(3))	ye)ars	(t
he	“Term”))Cha,	except	th)at	if
)any	Work	Order	is	still	in	progress	upon	the	ex
pir)at
ion	o
f	such	three	(3))
ye)ar

period,	the	Term	will	expire	upon	co
mpl
etion	of	t
h
e	rel)ated	Wo
rk	Order.		Upon	exp
ir)ation,	the	p)a
rties
m)ay	mutu)ally	)agree	to	renew

the	Term	for	)any	per
iod	specified	in	)a	written
)amendment	to	this	Agreement.
Otherwise,	neithe
r	p)ar
ty	sh
)all	h)ave	)any	rem)ainin
g	oblig)ation	)arising	under	this	Agree
men
t.

Termin)a
t
ion	sh)all
no
t	relieve	either	p)a
rty	of	oblig)ati
ons	incurred	prior	thereto.

B.

Term
ination.

I
n	)addition
to	the	rights	of	termin)atio
n	provided	elsewhere	in	this	Agreement,	)and	wit
hout
limit
ing	)any	other	rights
or	remedies	)av)ail)able	to	)a	p)arty,	the

Term	of	this

Agree
ment	m)a
y	be	termin)ated:

)a.

b
y	)Comp)any,	)at	)a
ny	time	within	three	hundred	)and
sixty	five	(365))Cla	d)ays

)after	the	Effective	D)ate	o
f
this	Agreement,	for	)any	re)ason,	immedi)ately	u
pon	w
ritte
n	notice	to	)Clinic)al
L)abor)atory;

b.

by	)Comp)any,	)at	)any
time	)after	th
r
ee	hundred	)a
nd	sixty	five	(365))

d)ays	)after	the

Effective	D)ate	of	this
Agreement
,	for	)any	re)ason,	upo
n	ninety	(90))Cha	d)ays	prior	wr
itten	notice	to	)Clinic)al	L)abor)atory;

d.			by	e
ither

p)art
y	bec)ause	of	)any	m)ate
ri)al	bre)ac
h	of	this	Agreement	by	the
other	p)arty	u
p
on

th
irty	(30))CIAa	d)ays	prio
r	written	notic
e;	provided,	however,	th)at	if	suc
h	bre)aching	p)arty	sh)a
ll

within	the	for
egoing	thirty	(30))Cga	d)ay	period	cure	such	bre)ach,

then

such

notice	of	termin)atio
n

sh)all	be	of	no	effect;	or

)a.

b
y	either	p)art
y

immedi)ately

upon	written	notic
e	in	the	event
th)at	the	other	p)arty	ce)ases	to
fu
nction
)as	)a	going	con
cern;	the	other	p)arty	ce)ase
s	to	conduct	its	oper)ation	in	the	norm)al
course

of	b
usine
ss;
)a	receiver	is	)app
ointed	for	the	other	p)arty;	)a	court	o
rders	the	sei
z
ure	or
suspe
nsion	of	the	other
p)arty’s	rights
or	properties;	or	the	other	p)arty

otherwise	t)akes

)adv)a
nt)age	of	)any	b)ankruptcy	or
insolvency	l)aw.

	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen

P
)age
8

of	11

C.

Effect	of	Termination
..	The
def
initi
ons	)a
nd
provisions	of
P
)art

7
,
8,	9B	)and	10

survive	expir)ation	o
r
termin)ation

of	this	Agre
ement	for	)any	re)aso
n.		Upon	expir)a
tion	or	termin)ation	of	this	Agree
ment,
)Clinic)al
L)abor)a
tory
’s	rights	)and	license	u
nder
P)art

1

sh)all	termin)ate.	In	)addition,	e)ach
p)arty

sh)al
l	ce)ase	use	of	the
ot
her
p)arty’s	)Confidenti)al	Inform)ation,

)and	e)ach	p)ar
t
y	sh)all	retu
rn	to	the	other	p)ar
ty	)all	of	such
other	p)arty’s
)Confidenti)al	Inform
)ation	(including	)all
copies,	notes,	summ)aries	or

other	document)ation	incorpor)ating
)Confidenti)al

Info
rm)ati
on))Cha,	m)ateri)als	)and	pr
oper
ty;	provided,	however,	th)at	e)ach
p)arty	m)ay	ret
)a
in	one	copy
of	)any	such	inform)a
tion	)and	m)ateri
)als	in	such	p)arty’s	L)aw	Dep)artmen
t	for	)archive	purpose
s,	)and	e)ach	p)arty
sh)all	not

be	required	to	destroy	or	delete	copies	th)at	h
)ave	b
ecome

embedded	in	its	elec
tron
ic	stor)age
systems	through	routin
e	b)ackup	proc
e
sses,	)and	fu
rther	provided	th)at

)Comp)any

m)ay	co
ntinue	ret)aining
)and/or	using	inf
orm)ation	included	in
reports	furnished	by
)Clinic
)al	L)abor)atory

pursu)ant	to
P)art

1	)and	2

)above,	s
olely

in	o
rder	to	verify
)Clinic
)al	L)abor)atory
’s	fulfilment	of	its	p)ay
ment	oblig)ati
o
ns	under	thi
s
Agreement.
Any	te
rmin)ation
of

)Cl
inic)al	L)abor)atory

by
)Comp)any
,

sh)a
ll	not	relieve
)Clinic
)al	L)abor)atory

of	)any
oblig)a
tion	or	li)ability	)accrued	under	this	Agreement
prior

to	s
uch	te
rmin)ation	or	re
scind	)any	p)ayment
..
Termin)ation	sh)all
not	)affect	in

)any	m)anner	)a
ny	rights	or	oblig)a
tion	of
)Comp)any

)arising	under	this	Agreement
pri
or	to	such	termin)atio
n.

P
ART
1
0
..	GENERAL	PROVISIONS

A.

Relationship	of	Parties.
The	rel)ati
onship	betwee
n

the	p)arties

est)ablished	by	thi
s	Agreement	sh)a
ll	be	solely
th)at	of	vendor	)and	v
endee	)and	)all	rights
)and	powers	not	expressly	gr
)anted	to	the
)Clinic)al	L)abor)atory
)are
expressly
reser
ved	t
o	the	)C
omp)any.	The
)Cl
inic)al	L)abor)atory
sh)all	h)ave	no	right
,	power	or	)au
t
hority	in	)an
y
w)ay	to	bind	the	)C
omp)any	to	the	f
ulfillment	of	)any	condition	not	h
erein	cont)ained,	or	t
o	)any	contr)act	or
oblig)atio
n,	expressed	or	implied.

B.

Independent	Parties.

Nothi
ng	co
nt)ained	in	this	Agree
ment	sh)all	be	construed	to	m)ake	the

)C
linic)al
L)abor
)a
tory
the	)age
nt	for	the	)Comp)any
for	)any	purpose
,	)and	neither	p)arty	hereto	sh)all
h)ave	)any	right
wh)atso
ever	to	incur	)any	li)abiliti
es	or	obli
g)ations	on	beh)alf	or	binding	upon	the

othe
r	p)ar
ty.	The
)Clinic)al
L)abo
r)atory

specific)ally	)agrees	th)at	it	sh
)all	h)ave	no	p
o
wer	or	)autho
rity	to	represent	t
he	)Comp)any

in	)any
m)anner;	th)at	it	will	solicit	o
rders	for	products	)as

)an	independent	contr)a
ctor
in	)accord)ance	with	the	terms	of
this	Agreement
;

)and	th)at
it	will	not	)at	)any	ti
me	represent	the	)Comp)any	in	)any	m)anne
r;	th)at	it	wi
l
l	solicit
or
ders	for	products	)a
s	)an	indep
endent	contr)actor	in	)accord)ance	with	t
he	terms	of	this	Agre
ement;	)and	th)at
it	wil
l	not

)at	)any	time	represent	or)ally	or	in	writing	to

)any	person

or	corpor)ation	or	ot
her	business	entity	th)at
it	h)as	)any	r
ight,	power	o
r

)authority	n
ot	expressly	gr)ante
d	by	this
Agreement.

C.

Indemnity.

)Clinic)al	L)abor
)atory	sh)all	indemnify
,	defend	)and	hold	h)armless
)Comp)any	)and	its	officers,
employees	)and	sh)areh
o
lders	(her
ein	referred	to	joint
ly	)and	sever)ally	)as	“
)Comp)any	Indemnit
ees
”))Cla	from	)an
d

)ag)ainst	)any

third	p)arty	cl)aim,

)and	)all	r
esulting	)and/or	rel)a
ted	li)ability,	d)am
)age,	loss,	costs	)and
expenses
including	re)ason)ab
le	out	of
-
pocket	leg)al	costs,	re)ason)able	out	o
f
-
pocket	)at
torneys’	fees	)and	lit
ig)ation
expenses	incurred	by	or	impos
ed	upon	the	)C
o
mp)any	Indemn
itees	)as	)a	result	o
f	)and/or	)a
rising	from:	(i))	the

development,	m)ark
eting,	s)ale,	perform)a
nce,	use	or	other	commerci)a
liz)ation	)and/or	exploit)ation	of	)any
Service	by

)Clinic)al	L
)abor)atory	or	)any	pers
on	)acting	in	the	n)ame	of	or	on	beh)alf

of	)any	of	th
e

foregoing,
or
)acquiring,	direc
tly	or	ind
irectly,	)any	Service

from	)any	of	the	f
oregoing;	(ii))Cha	the	ex
ploit)ation	or	use	of	produc
t
kit	by	)Clinic)al	L)abor)atory;	(iii))Cla	)and/or	bre
)a
ch	of	this

Agreement	by	)Clinic)a
l	L)abor)atory’s.		Notwithst)anding	the
foregoing,	th
e

foregoing	o
blig)ation	of	)Clinic
)al	L)abor)at
ory	sh)all	not	)apply
to	the	extent	th)at

)any	cl)aim	rel)ates
to

or	)arises	from	)any	misrepr
esent)ation,	negligence	or	willful	misconduct	o
f

)Comp)any,
or	from	)Comp)any’s
bre
)ach	of	this	Agreement.

	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen

P
)age
9

of	11

D.

Assign
ment.

Neither

this	Agreeme
nt	nor	the	respecti
ve	rights
)and	oblig)ations	of	the	p)arties	under	t
his
Agreement	m)ay	be
)assigned,	tr)ansferred,	dele
g)ated	or
subcontr)acted	in	whole	or	in	p)art,	by

either	p)ar
ty	to
)any	other	Entit
y	without	the	prior	written	consent	o
f	the	other	p
)a
rty	which	co
nsent	sh)all	not	be
unre)ason)ab
ly	denied,	conditioned	or	del)ayed.	Not
withst)anding	the	fore
going,	)Comp)any	sh)all	be	ent
itled	to
)assign	this	Agreement	(in	whole	or	in

p)art))Cha	or	i
ts	rights	)and	oblig)at
ions	hereunder	to	)an	Affili)ate	or	to
)a	third
p)arty

th)at	succeed
s	to	)all	or	subst)an
ti)ally	)all

of	the	business	or	)assets	of	)Comp)any
rel)ating	to	this	Agre
ement
whether	by	s)ale,	merg
er,	oper)a
tion	of	l)aw	or	otherwise,	provided	in

e)ach	c)ase
th)at	such	)assignee	)ag
rees	to
be	bound	in	writing	by	the	te
rms	of	this	A
g
reement.	Sub
ject	to	the	prior	s
entence,	t
he	rights,	duties,	)and
oblig)ations	of
the	p)arties	under	thi
s	Agreement	sh)all	inure	to
the	benef
it	)and	sh)all	be	binding	upon	their
re
s
pective	su
ccessors	)and	permitte
d	)assigns.

E.

Insurance
..

)Clinic)al	L)ab
or)atory	sh)all

procure	)and
m)aint)ain,	)at	its	so
le	cost	)an
d	expense,	insur)ance	policies	in
)amoun
ts	re)ason)able	)and	cus
tom)ary	in	the	industry	)and
sufficient	to	cover	its	li)abilities	)and	oblig)a
t
ions	under

this	Agreement,	t)aki
ng	into	)account	the	)actu
)al	st)age	of	S
ervice	develo
p
ment	)and	com
merci)aliz)ation	of	)a
ny
product

kit.

The	insur)ance	cover)age	required
)above	sh)all	not	be	co
nstrued	to	cre)ate	)a	limit	o
f	)Clinic)al
L)abor)atory’s	li)ability	with	respect

to	its	ind
emnific)ation	oblig)ati
ons	under	the	)above	Sec
tion.

)Clinic)al

L)abor)atory	s
h
)all	provide
)Comp)any	with	writte
n	evidence

of	such	insur)ance	upon	request.

F.

Own
ership
..

For	purposes
of	cl)arific)ation,	the	p)arti
es	)acknowledge	)and	)agree	th)at	this	Agreement	i
s

not
inten
ded	to	nor	)assigns	or

wi
ll	)assign,	or	tr)ansfer	)any	ownersh
ip	of	intelle
c
tu)al	propert
y	or	know
-
how	owned

by	)Comp)an
y	to	)Clinic)al	L)abor)atory.		Inventorshi
p	of	)any	invention	in
vented	or	cre)ated	in	connec
tion	with
this	Agreement	will	be	determined	by

United	St)a
tes	p)atent	l)aw,	)and	o
wne
rship	sh)all	follow	inventorship.

G.

Status	of	P
a
rties
..

This
Agreement	cre)ates	n
o	rel)ation
ship	of	joint	venturers,	p)artners,	or
princip)al	)and	)agent
b
etween	the	p)arties.		Furthe
r,	neither	p)arty	sh)all	be	)authorized	to	)act	on

beh)alf	of,

or	ot
herwise	bind	th
e
other	p)arty.

H.

Notices
..

Any	notice	c
ontempl)ated	o
r

required	or

permitted	to	be	gi
ven	under
this	Agreement	(including
without	limi
t)ation	invoices	)and	b
illing	inform)ation))CIAa	sh)all	b
e	sufficient	if	in	writing	)and	prep)aid	)and	if
(
i))CIAa
deliver
ed	person)ally,	(ii))Cga	s
ent	by	registered	or	cer
tified	m)ail,
return	receip
t

requested,
or	(iii))Cha	sent	by	ex
press
deli
very	service	(such	)as	Feder)al	Express))

where	the	recipient
must	execute	its	receipt,	t
o	the	p)arties’
respective	)addresses	below,	or
t
o	such	oth
er	)addresses	)as	eithe
r	p)arty	hereto	m)ay	here)a
fter	design)at
e	in
writing.

Non)ag
en
:

Non)agen	Biosci
ence	)Corp.

Attn:

Business

Development

3680	Wilsh
ire	Blvd,	Ste	P04
-

1
399

Los	Angeles,	)CA	90010

Di)a)C)art)a
:

Aiguo	Zh)ang,	Ph.D.

Di)a)C)art)a	Inc.

4385	Hopy)a
rd	Rd,	Ste	100

Ple)as)a
nton,	)CA	94588

United	St)ates	of	Ameri
c)a

With	co
p
y

for	Notice

purposes,	to
:

with	)a	copy	sent	to
:

	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen

P
)age
10

of	11

I.

E
ntire	Agr
e
ement.

The

entire	Agreement	between	the	)Comp)any	)and	the
)Clinic)al	L)abor)a
t
ory

covering

the
Product

Kit

is	set	forth	herein	)and

)any	)amendment	or	modific)ation	sh)all
b
e	in	writing	)and	sh)all	be	executed
by

duly	)au
thorized	represent)ativ
es	in	the	s)ame	m)a
nner	)as	t
h
is	Agreeme
nt.	The
provisions	of	this	Agreement
)are	sever)able,	)and	if	)an
y

one	or	more

such	provisions	)are	determined	to	be	il
leg)al	or	otherwise
unenforce)able,	in
w
hole	or	in	p)art,	under	the	l)aws	of	)an
y	jurisd
iction,	the	rem)aining
provisions	or	por
tions
her
e
of	sh)all,
neverthe
less,	be	binding	on	)and	enforce)able	by	)and	between	th
e

p)arties	her
eto.	Any
provisions,	terms	or	conditions

of
)Clinic)al	L)abor)atory

's	Purch)ase	O
r
ders	which	)are,	in	)any	w)ay	contr)adict
ing
of	t
his	Agreeme
nt,	except	those	)addition)al
provision
s

specifyin
g	qu)antity	)and	sh
ipping	instructions,	sh)all	not
be	binding	up
o
n	)Comp)any	)an
d	sh)all	h)ave	no	)applic)ability	to	the	s)ale	of	good
s	by	)Comp)any	to
)Clinic)al
L)ab
o
r)atory
..

J.

Publicity.

E)ach	p)arty	is	fr
ee	to	m)a
ke	public	the	existence	of	this	Agreeme
nt	once	s
i
gned	by	bo
th	P)arties.	The
P)arties	)a
gree	to	m)ake	every	best	effort	to	jo
i
ntly	publici
ze	this	Agreement.

K.

Applicable	Law.

This	Agreement	sets
out	the	entire	)agree
m
ent	)and	underst)anding	between	)Comp)any

)and
)Cli
nic)al	L)abor)atory

)and	sh)all	be	governed
by	)and	co
n
strued	in
)accord)ance	with	the	l)aws	of	the	S
t)ate	of
New
York
;	)and	)Comp)an
y

)and
)Clinic)a
l	L)abor)atory

hereby	irrevoc)ably	submit	to	the	exclusive	jurisdiction	of	t
he
c
o
urts	of	the	St)ate	of
Ne
w
York
..

L.

Sepa
rate	Pro
visions.

If	)any	provision	of	this	Agree
ment	sh)al
l

be	held	t
o	be	i
nv)alid,	illeg)al	or	unenforce)able,
the	v)alidity,	leg)alit
y

)and	enforce
)ability	of	the	rem)aining	provisions	sh)all	in	no	w)ay	be	)affected	or	imp)air
ed
t
h
ereby.

M.

Miscellaneous
..

This	Agreemen
t	m)ay	be

executed	in	counterp)arts	in	order	to	p
rovide	e)a
c
h	p)arty	wi
th	)a	fully
-
executed	origin)al	hereof.		This	Agreement	m)ay	not
b
e	ch)anged,	m
odified	or	)amended	except	by	)an
)agreement	in	writing	signed	by	both	p)arti
es.

The	provisions	of	this
Agreement	)are
hereby	d
eemed	by	the
p)arties	to	be	sever)able,	)a
nd	the	in
v
)alidity	or

unenforce)ability	of	)any	one	or	more	of	the	provisions	of	thi
s

Agreement	s
h)all	not	)affect	the	v)alidity	)and	enforce)ability	of	the	rem)aining	provisio
ns	t
h
ereof.		The	w)aiver	by
)a
ny	p)arty	to	th
is	Agree
ment	of	)any	bre)ach	or	viol)ation	of	)any
provision
s

of	this	A
greement	by	)any	other
p)arty	hereto	sh)all	not	oper)ate	)as	)a	w)ai
v
er	of	)any	ot
her	bre)ach.		Titles	)and	he)adings	of	sections	of	this
Agreement	)are	for	co
nven
i
ence	)and	reference	only

)and	sh)all	not

)affect
the	construction	of	)any	provisions	of
t
his	Agree
m
ent.		This

Agreement	reflects	the	complete	underst)anding	of	the	p)arties

)and	constitu
tes	their
entire	)agreement	reg)arding	its	subject	m)atter,	superseding	)all
prio
r

verb)al	or	written	nego
ti)ations,
repr
esent)ati
ons,	)agreements,	underst)andings,	)and	st
)atements
r
eg)arding	t
he	subject	m)atter	herein.

IN	WITNESS	WHEREOF,	the	p)arties	h)a
v
e	c)aused	thi
s	Agreement	to	be	executed	by	their	duly	)authorized	officers
)as	of	the	d)a
te	)a
n
d	ye)ar	indic)ated	)ab
ove.

COMPANY

CLIN
ICAL	LABORATORY

By:	_________________________________

By:

)Ch)arles
Rosser

Aiguo	Zh)ang,	Ph.D

)CE
O

)CEO

Non)agen	B
ioscience	)Corpor)ation

Di)a)C)art)a,	Inc

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]